1. Altered Skin and Gut Microbiome in Hidradenitis Suppurativa.
- Author
-
McCarthy S, Barrett M, Kirthi S, Pellanda P, Vlckova K, Tobin AM, Murphy M, Shanahan F, and O'Toole PW
- Subjects
- Adult, Aged, Case-Control Studies, Clostridiales immunology, Clostridiales isolation & purification, Extracellular Traps immunology, Fecal Microbiota Transplantation, Feces microbiology, Female, Firmicutes immunology, Firmicutes isolation & purification, Hidradenitis Suppurativa immunology, Hidradenitis Suppurativa pathology, Hidradenitis Suppurativa therapy, Humans, Male, Middle Aged, Skin immunology, Skin pathology, Young Adult, Gastrointestinal Microbiome immunology, Hidradenitis Suppurativa microbiology, Skin microbiology
- Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by the formation of nodules, abscesses, and fistulae at intertriginous sites. The skin-gut axis is an area of emerging research in inflammatory skin disease and is a potential contributory factor to the pathogenesis of HS. A total of 59 patients with HS provided fecal samples and nasal and skin swabs of affected sites for analysis. A total of 30 healthy controls provided fecal samples, and 20 healthy controls provided nasal and skin swabs. We performed bacterial 16S ribosomal RNA gene amplicon sequencing on total DNA derived from the samples. Microbiome alpha diversity was significantly lower in the fecal, skin, and nasal samples of individuals with HS, which may be secondary to disease biology or related to antibiotic usage. Ruminococcus gnavus was more abundant in the fecal microbiome of individuals with HS, which is also reported in Crohn's disease, suggesting comorbidity due to shared gut microbiota alterations. Finegoldia magna was overabundant in HS skin samples relative to that in the healthy controls. It is possible that local inflammation is driven by F. magna by promoting the formation of neutrophil extracellular traps. These alterations in both the gut and skin microbiome in HS warrant further exploration, and therapeutic strategies, including fecal microbiota transplant or bacteriotherapy, could be of benefit., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF